264 related articles for article (PubMed ID: 30611103)
1. Current pharmaceutical developments in atopic dermatitis.
Misery L; Huet F; Gouin O; Ständer S; Deleuran M
Curr Opin Pharmacol; 2019 Jun; 46():7-13. PubMed ID: 30611103
[TBL] [Abstract][Full Text] [Related]
2. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
Soeberdt M; Kilic A; Abels C
Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
[TBL] [Abstract][Full Text] [Related]
3. Drugs on the Horizon for Chronic Pruritus.
McEwen MW; Fite EM; Yosipovitch G; Patel T
Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
[TBL] [Abstract][Full Text] [Related]
4. JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.
Huang IH; Chung WH; Wu PC; Chen CB
Front Immunol; 2022; 13():1068260. PubMed ID: 36569854
[TBL] [Abstract][Full Text] [Related]
5. JAK/STAT inhibitors for the treatment of atopic dermatitis.
Rodrigues MA; Torres T
J Dermatolog Treat; 2020 Feb; 31(1):33-40. PubMed ID: 30703333
[No Abstract] [Full Text] [Related]
6. New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines.
Renert-Yuval Y; Guttman-Yassky E
Ann Allergy Asthma Immunol; 2020 Jan; 124(1):28-35. PubMed ID: 31622669
[TBL] [Abstract][Full Text] [Related]
7. Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses.
Garcia-Melendo C; Cubiró X; Puig L
Actas Dermosifiliogr (Engl Ed); 2021; 112(7):586-600. PubMed ID: 34030992
[TBL] [Abstract][Full Text] [Related]
8. Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors.
Nakashima C; Yanagihara S; Otsuka A
Allergol Int; 2022 Jan; 71(1):40-46. PubMed ID: 34815171
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease.
Howell MD; Fitzsimons C; Smith PA
Ann Allergy Asthma Immunol; 2018 Apr; 120(4):367-375. PubMed ID: 29454096
[TBL] [Abstract][Full Text] [Related]
10. Emerging treatments for atopic dermatitis.
Katoh N
J Dermatol; 2021 Feb; 48(2):152-157. PubMed ID: 32677122
[TBL] [Abstract][Full Text] [Related]
11. Innovation in Atopic Dermatitis: From Pathogenesis to Treatment.
Munera-Campos M; Carrascosa JM
Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):205-221. PubMed ID: 31964499
[TBL] [Abstract][Full Text] [Related]
12. Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.
Chu CY
Clin Rev Allergy Immunol; 2021 Oct; 61(2):114-127. PubMed ID: 32607924
[TBL] [Abstract][Full Text] [Related]
13. Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives.
Munera-Campos M; Carrascosa JM
Actas Dermosifiliogr; 2023 Sep; 114(8):680-707. PubMed ID: 37105270
[TBL] [Abstract][Full Text] [Related]
14. Novel therapies and the potential for a personalized approach to atopic dermatitis.
Balakirski G; Novak N
Curr Opin Allergy Clin Immunol; 2021 Aug; 21(4):368-377. PubMed ID: 34074875
[TBL] [Abstract][Full Text] [Related]
15. Abrocitinib for the treatment of atopic dermatitis.
Crowley EL; Nezamololama N; Papp K; Gooderham MJ
Expert Rev Clin Immunol; 2020 Oct; 16(10):955-962. PubMed ID: 32969750
[TBL] [Abstract][Full Text] [Related]
16. JAK-inhibitors in dermatology: current evidence and future applications.
Ciechanowicz P; Rakowska A; Sikora M; Rudnicka L
J Dermatolog Treat; 2019 Nov; 30(7):648-658. PubMed ID: 30433838
[TBL] [Abstract][Full Text] [Related]
17. JAK-STAT signaling pathway inhibition: a role for treatment of various dermatologic diseases.
Kahn J; Deverapalli SC; Rosmarin D
Semin Cutan Med Surg; 2018 Sep; 37(3):198-208. PubMed ID: 30215638
[TBL] [Abstract][Full Text] [Related]
18. [New aspects in systemic treatment of atopic dermatitis].
Werfel T; Wollenberg A; Pumnea T; Heratizadeh A
Hautarzt; 2018 Mar; 69(3):217-224. PubMed ID: 29470609
[TBL] [Abstract][Full Text] [Related]
19. Exploring the role of Janus kinase (JAK) in atopic dermatitis: a review of molecular mechanisms and therapeutic strategies.
Kogame T; Egawa G; Kabashima K
Immunol Med; 2023 Sep; 46(3):112-120. PubMed ID: 37254967
[TBL] [Abstract][Full Text] [Related]
20. Emerging therapies for atopic dermatitis: JAK inhibitors.
Cotter DG; Schairer D; Eichenfield L
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S53-S62. PubMed ID: 29248518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
